$ARPO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aerpio Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aerpio Pharmaceuticals, Inc.. Get notifications about new insider transactions in Aerpio Pharmaceuticals, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | ARPO | Aerpio Pharmaceuti ... | Cohen Cheryl | Director | Grant | A | 1.54 | 8,020 | 12,375 | 8,020 | 0 to 8 K |
Apr 02 2021 | ARPO | Aerpio Pharmaceuti ... | Dalal Anupam | Director | Grant | A | 1.54 | 7,290 | 11,248 | 9,559 | 2.3 K to 9.6 K (+321.29 %) |
Apr 02 2021 | ARPO | Aerpio Pharmaceuti ... | Dugel Pravin | Director | Grant | A | 1.54 | 6,237 | 9,624 | 6,237 | 0 to 6.2 K |
Apr 02 2021 | ARPO | Aerpio Pharmaceuti ... | Prelack Steven | Director | Grant | A | 1.54 | 12,151 | 18,749 | 12,151 | 0 to 12.2 K |
Apr 02 2021 | ARPO | Aerpio Pharmaceuti ... | Castelein Caley | Director | Grant | A | 1.54 | 7,696 | 11,875 | 287,603 | 279.9 K to 287.6 K (+2.75 %) |
Feb 03 2021 | ARPO | Aerpio Pharmaceuti ... | Cohen Cheryl | Director | Option Exercise | A | 1.46 | 17,857 | 26,071 | 17,857 | |
Feb 03 2021 | ARPO | Aerpio Pharmaceuti ... | Castelein Caley | Director | Option Exercise | A | 1.46 | 17,857 | 26,071 | 17,857 | |
Feb 03 2021 | ARPO | Aerpio Pharmaceuti ... | Dalal Anupam | Director | Option Exercise | A | 1.46 | 17,857 | 26,071 | 17,857 | |
Feb 03 2021 | ARPO | Aerpio Pharmaceuti ... | Dugel Pravin | Director | Option Exercise | A | 1.46 | 17,857 | 26,071 | 17,857 | |
Dec 10 2020 | ARPO | Aerpio Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | X | 0.96 | 21,400 | 20,544 | 0 | |
Dec 10 2020 | ARPO | Aerpio Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.96 | 21,400 | 41,944 | 0 | 21.4 K to 0 (-100.00 %) |
Dec 10 2020 | ARPO | Aerpio Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | X | 0.96 | 21,400 | 20,544 | 21,400 | 0 to 21.4 K |
Jun 26 2020 | ARPO | Aerpio Pharmaceuti ... | Dugel Pravin | Director | Option Exercise | A | 1.22 | 52,144 | 63,616 | 52,144 | |
Jun 26 2020 | ARPO | Aerpio Pharmaceuti ... | Dalal Anupam | Director | Option Exercise | A | 1.22 | 52,144 | 63,616 | 52,144 | |
Jun 26 2020 | ARPO | Aerpio Pharmaceuti ... | Castelein Caley | Director | Option Exercise | A | 1.22 | 52,144 | 63,616 | 52,144 | |
Jun 26 2020 | ARPO | Aerpio Pharmaceuti ... | Prelack Steven | Director | Option Exercise | A | 1.22 | 52,144 | 63,616 | 52,144 | |
Jun 26 2020 | ARPO | Aerpio Pharmaceuti ... | Cohen Cheryl | Director | Option Exercise | A | 1.22 | 52,144 | 63,616 | 52,144 | |
Mar 18 2020 | ARPO | Aerpio Pharmaceuti ... | Gardner Joseph H. | President | Option Exercise | A | 0.52 | 155,000 | 80,616 | 155,000 | |
Mar 18 2020 | ARPO | Aerpio Pharmaceuti ... | PETERS KEVIN G. | See Remarks | Option Exercise | A | 0.52 | 129,000 | 67,093 | 129,000 | |
Mar 18 2020 | ARPO | Aerpio Pharmaceuti ... | Marek Regina | Vice President of F ... | Option Exercise | A | 0.52 | 93,000 | 48,369 | 93,000 | |
Nov 06 2019 | ARPO | Aerpio Pharmaceuti ... | Marek Regina | Vice President of F ... | Option Exercise | A | 0.56 | 44,300 | 24,755 | 44,300 | |
Jul 10 2019 | ARPO | Aerpio Pharmaceuti ... | Gardner Joseph H. | President | Buy | P | 0.81 | 5,000 | 4,074 | 453,019 | 448 K to 453 K (+1.12 %) |
Jul 08 2019 | ARPO | Aerpio Pharmaceuti ... | Gardner Joseph H. | President | Buy | P | 0.90 | 5,000 | 4,485 | 448,019 | 443 K to 448 K (+1.13 %) |
Jun 19 2019 | ARPO | Aerpio Pharmaceuti ... | Dalal Anupam | Director | Option Exercise | A | 0.96 | 21,400 | 20,544 | 21,400 | |
Jun 19 2019 | ARPO | Aerpio Pharmaceuti ... | Castelein Caley | Director | Option Exercise | A | 0.96 | 21,400 | 20,544 | 21,400 | |
Jun 19 2019 | ARPO | Aerpio Pharmaceuti ... | Khuong Chau Quang | Director | Option Exercise | A | 0.96 | 21,400 | 20,544 | 21,400 | |
Jun 19 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Option Exercise | A | 0.96 | 21,400 | 20,544 | 21,400 | |
Jun 19 2019 | ARPO | Aerpio Pharmaceuti ... | Dugel Pravin | Director | Option Exercise | A | 0.96 | 21,400 | 20,544 | 21,400 | |
Jun 19 2019 | ARPO | Aerpio Pharmaceuti ... | Cohen Cheryl | Director | Option Exercise | A | 0.96 | 21,400 | 20,544 | 21,400 | |
Jun 19 2019 | ARPO | Aerpio Pharmaceuti ... | Prelack Steven | Director | Option Exercise | A | 0.96 | 21,400 | 20,544 | 21,400 | |
May 16 2019 | ARPO | Aerpio Pharmaceuti ... | HOFFMAN STEPHEN J | Chief Executive Off ... | Option Exercise | A | 1.04 | 709,050 | 737,412 | 709,050 | |
May 16 2019 | ARPO | Aerpio Pharmaceuti ... | PETERS KEVIN G. | See Remarks | Option Exercise | A | 1.04 | 266,550 | 277,212 | 266,550 | |
May 16 2019 | ARPO | Aerpio Pharmaceuti ... | PETERS KEVIN G. | See Remarks | Option Exercise | A | 1.04 | 63,250 | 65,780 | 63,250 | |
Apr 29 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.03 | 138,704 | 142,865 | 4,049,804 | 4.2 M to 4 M (-3.31 %) |
Apr 29 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.03 | 563,096 | 579,989 | 4,188,508 | 4.8 M to 4.2 M (-11.85 %) |
Apr 24 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.03 | 16,403 | 16,895 | 4,751,604 | 4.8 M to 4.8 M (-0.34 %) |
Apr 24 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.03 | 27,554 | 28,381 | 4,768,007 | 4.8 M to 4.8 M (-0.57 %) |
Apr 24 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.97 | 7,100 | 6,887 | 4,795,561 | 4.8 M to 4.8 M (-0.15 %) |
Apr 15 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.99 | 28,794 | 28,506 | 4,802,661 | 4.8 M to 4.8 M (-0.60 %) |
Apr 15 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.04 | 30,908 | 32,144 | 4,831,455 | 4.9 M to 4.8 M (-0.64 %) |
Apr 15 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.08 | 57,438 | 62,033 | 4,862,363 | 4.9 M to 4.9 M (-1.17 %) |
Apr 10 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.09 | 140,230 | 152,851 | 4,919,801 | 5.1 M to 4.9 M (-2.77 %) |
Apr 10 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.01 | 32,991 | 33,321 | 5,060,031 | 5.1 M to 5.1 M (-0.65 %) |
Apr 10 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.02 | 27,525 | 28,076 | 5,093,022 | 5.1 M to 5.1 M (-0.54 %) |
Apr 05 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.02 | 24,661 | 25,154 | 5,120,547 | 5.1 M to 5.1 M (-0.48 %) |
Apr 05 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.01 | 47,900 | 48,379 | 5,145,208 | 5.2 M to 5.1 M (-0.92 %) |
Apr 05 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.96 | 58,033 | 55,712 | 5,193,108 | 5.3 M to 5.2 M (-1.11 %) |
Apr 02 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.97 | 51,754 | 50,201 | 5,251,141 | 5.3 M to 5.3 M (-0.98 %) |
Apr 02 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.95 | 116,909 | 111,064 | 5,302,895 | 5.4 M to 5.3 M (-2.16 %) |
Apr 02 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.91 | 63,100 | 57,421 | 5,419,804 | 5.5 M to 5.4 M (-1.15 %) |
Mar 28 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.94 | 88,835 | 83,505 | 5,482,904 | 5.6 M to 5.5 M (-1.59 %) |
Mar 28 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 0.99 | 50,749 | 50,242 | 5,571,739 | 5.6 M to 5.6 M (-0.90 %) |
Mar 28 2019 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.01 | 177,762 | 179,540 | 5,622,488 | 5.8 M to 5.6 M (-3.06 %) |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | PAKOLA STEVE | Chief Medical Offic ... | Option Exercise | A | 3.27 | 125,000 | 408,750 | 125,000 | |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | Gardner Joseph H. | President | Option Exercise | A | 3.27 | 150,000 | 490,500 | 150,000 | |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | HOFFMAN STEPHEN J | Chief Executive Off ... | Option Exercise | A | 3.27 | 365,000 | 1,193,550 | 365,000 | |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | PETERS KEVIN G. | Chief Scientific Of ... | Option Exercise | A | 3.27 | 125,000 | 408,750 | 125,000 | |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | Gardner Joseph H. | President | Option Exercise | A | 3.27 | 150,000 | 490,500 | 150,000 | |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | HOFFMAN STEPHEN J | Chief Executive Off ... | Option Exercise | A | 3.27 | 365,000 | 1,193,550 | 365,000 | |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | PETERS KEVIN G. | Chief Scientific Of ... | Option Exercise | A | 3.27 | 125,000 | 408,750 | 125,000 | |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 3.27 | 215,328 | 704,123 | 215,328 | |
Feb 20 2019 | ARPO | Aerpio Pharmaceuti ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 3.27 | 215,328 | 704,123 | 215,328 | |
Jan 10 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.45 | 23,818 | 58,442 | 5,621,835 | 5.6 M to 5.6 M (+0.43 %) |
Jan 10 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.39 | 20,000 | 47,876 | 5,598,017 | 5.6 M to 5.6 M (+0.36 %) |
Jan 10 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.20 | 20,000 | 43,972 | 5,578,017 | 5.6 M to 5.6 M (+0.36 %) |
Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.18 | 20,000 | 43,558 | 5,558,017 | 5.5 M to 5.6 M (+0.36 %) |
Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.18 | 20,000 | 43,558 | 5,558,017 | 5.5 M to 5.6 M (+0.36 %) |
Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.12 | 20,000 | 42,396 | 5,538,017 | 5.5 M to 5.5 M (+0.36 %) |
Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.12 | 20,000 | 42,396 | 5,538,017 | 5.5 M to 5.5 M (+0.36 %) |
Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.08 | 20,000 | 41,508 | 5,518,017 | 5.5 M to 5.5 M (+0.36 %) |
Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.08 | 20,000 | 41,508 | 5,518,017 | 5.5 M to 5.5 M (+0.36 %) |
Jan 02 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.94 | 20,000 | 38,838 | 5,498,017 | 5.5 M to 5.5 M (+0.37 %) |
Jan 02 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.75 | 20,000 | 34,900 | 5,478,017 | 5.5 M to 5.5 M (+0.37 %) |
Jan 02 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.72 | 20,000 | 34,372 | 5,458,017 | 5.4 M to 5.5 M (+0.37 %) |
Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.67 | 20,000 | 33,410 | 5,438,017 | 5.4 M to 5.4 M (+0.37 %) |
Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.69 | 20,000 | 33,854 | 5,418,017 | 5.4 M to 5.4 M (+0.37 %) |
Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.84 | 20,000 | 36,870 | 5,398,017 | 5.4 M to 5.4 M (+0.37 %) |
Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.67 | 20,000 | 33,410 | 5,438,017 | 5.4 M to 5.4 M (+0.37 %) |
Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.69 | 20,000 | 33,854 | 5,418,017 | 5.4 M to 5.4 M (+0.37 %) |
Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.84 | 20,000 | 36,870 | 5,398,017 | 5.4 M to 5.4 M (+0.37 %) |
Dec 20 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.85 | 20,000 | 36,984 | 5,378,017 | 5.4 M to 5.4 M (+0.37 %) |
Dec 20 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.92 | 20,000 | 38,384 | 5,358,017 | 5.3 M to 5.4 M (+0.37 %) |
Dec 20 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.99 | 20,000 | 39,856 | 5,338,017 | 5.3 M to 5.3 M (+0.38 %) |
Dec 14 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.00 | 20,000 | 40,094 | 5,318,017 | 5.3 M to 5.3 M (+0.38 %) |
Dec 14 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.02 | 20,000 | 40,308 | 5,298,017 | 5.3 M to 5.3 M (+0.38 %) |
Dec 14 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.05 | 20,000 | 40,938 | 5,278,017 | 5.3 M to 5.3 M (+0.38 %) |
Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.09 | 20,000 | 41,846 | 5,258,017 | 5.2 M to 5.3 M (+0.38 %) |
Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.09 | 20,000 | 41,846 | 5,258,017 | 5.2 M to 5.3 M (+0.38 %) |
Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.13 | 20,000 | 42,608 | 5,238,017 | 5.2 M to 5.2 M (+0.38 %) |
Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.13 | 20,000 | 42,608 | 5,238,017 | 5.2 M to 5.2 M (+0.38 %) |
Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.14 | 20,000 | 42,788 | 5,218,017 | 5.2 M to 5.2 M (+0.38 %) |
Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.14 | 20,000 | 42,788 | 5,218,017 | 5.2 M to 5.2 M (+0.38 %) |
Dec 06 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.18 | 20,000 | 43,584 | 5,198,017 | 5.2 M to 5.2 M (+0.39 %) |
Dec 06 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.10 | 20,000 | 41,994 | 5,178,017 | 5.2 M to 5.2 M (+0.39 %) |
Dec 06 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.99 | 20,000 | 39,774 | 5,158,017 | 5.1 M to 5.2 M (+0.39 %) |
Nov 30 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.98 | 20,000 | 39,692 | 5,138,017 | 5.1 M to 5.1 M (+0.39 %) |
Nov 30 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.01 | 20,000 | 40,118 | 5,118,017 | 5.1 M to 5.1 M (+0.39 %) |
Nov 30 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.94 | 20,000 | 38,714 | 5,098,017 | 5.1 M to 5.1 M (+0.39 %) |
Nov 16 2018 | ARPO | Aerpio Pharmaceuti ... | Dugel Pravin | Director | Option Exercise | A | 2.05 | 2,500 | 5,125 | 2,500 | |
Sep 26 2018 | ARPO | Aerpio Pharmaceuti ... | Castelein Caley | Director | Sell | D | 0.00 | 1,603,526 | 0 | 0 | 1.6 M to 0 (-100.00 %) |
Sep 26 2018 | ARPO | Aerpio Pharmaceuti ... | Castelein Caley | Director | Buy | J | 0.00 | 268,987 | 0 | 279,907 | 10.9 K to 279.9 K (+2,463.25 %) |
Aug 22 2018 | ARPO | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.90 | 5,300 | 20,670 | 5,800,250 | 5.8 M to 5.8 M (-0.09 %) |
Jul 02 2018 | ARPO | Aerpio Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.85 | 777,500 | 2,993,375 | 5,193,946 | 4.4 M to 5.2 M (+17.60 %) |
Jul 02 2018 | ARPO | Aerpio Pharmaceuti ... | Khuong Chau Quang | Director | Buy | P | 3.85 | 777,500 | 2,993,375 | 5,193,946 | 4.4 M to 5.2 M (+17.60 %) |
Jul 02 2018 | ARPO | Aerpio Pharmaceuti ... | Khuong Chau Quang | Director | Buy | P | 3.85 | 777,500 | 2,993,375 | 5,193,946 | 4.4 M to 5.2 M (+17.60 %) |
Jun 29 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 3.85 | 1,818,182 | 7,000,001 | 5,078,017 | 3.3 M to 5.1 M (+55.78 %) |
Jun 22 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Option Exercise | A | 4.00 | 21,400 | 85,600 | 21,400 | |
Jun 22 2018 | ARPO | Aerpio Pharmaceuti ... | Dalal Anupam | Director | Option Exercise | A | 4.00 | 21,400 | 85,600 | 21,400 | |
Jun 22 2018 | ARPO | Aerpio Pharmaceuti ... | Khuong Chau Quang | Director | Option Exercise | A | 4.00 | 21,400 | 85,600 | 21,400 | |
Jun 22 2018 | ARPO | Aerpio Pharmaceuti ... | Dugel Pravin | Director | Option Exercise | A | 4.00 | 21,400 | 85,600 | 21,400 | |
Jun 22 2018 | ARPO | Aerpio Pharmaceuti ... | Prelack Steven | Director | Option Exercise | A | 4.00 | 21,400 | 85,600 | 21,400 | |
Jun 22 2018 | ARPO | Aerpio Pharmaceuti ... | Castelein Caley | Director | Option Exercise | A | 4.00 | 21,400 | 85,600 | 21,400 | |
Jun 22 2018 | ARPO | Aerpio Pharmaceuti ... | Cohen Cheryl | Director | Option Exercise | A | 4.00 | 42,800 | 171,200 | 42,800 | |
Apr 25 2018 | ARPO | Aerpio Pharmaceuti ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 3.59 | 144,000 | 516,960 | 144,000 | |
Apr 25 2018 | ARPO | Aerpio Pharmaceuti ... | PAKOLA STEVE | Chief Medical Offic ... | Option Exercise | A | 3.59 | 100,000 | 359,000 | 100,000 | |
Apr 25 2018 | ARPO | Aerpio Pharmaceuti ... | Gardner Joseph H. | President | Option Exercise | A | 3.59 | 150,000 | 538,500 | 150,000 | |
Apr 25 2018 | ARPO | Aerpio Pharmaceuti ... | HOFFMAN STEPHEN J | Chief Executive Off ... | Option Exercise | A | 3.59 | 300,000 | 1,077,000 | 300,000 | |
Apr 25 2018 | ARPO | Aerpio Pharmaceuti ... | PETERS KEVIN G. | Chief Scientific Of ... | Option Exercise | A | 3.59 | 100,000 | 359,000 | 100,000 | |
Apr 25 2018 | ARPO | Aerpio Pharmaceuti ... | HOFFMAN STEPHEN J | Chief Executive Off ... | Option Exercise | A | 3.59 | 300,000 | 1,077,000 | 300,000 | |
Apr 25 2018 | ARPO | Aerpio Pharmaceuti ... | PETERS KEVIN G. | Chief Scientific Of ... | Option Exercise | A | 3.59 | 100,000 | 359,000 | 100,000 | |
Mar 23 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 5.00 | 1,000 | 5,000 | 3,259,835 | 3.3 M to 3.3 M (+0.03 %) |
Mar 23 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 4.85 | 4,000 | 19,390 | 3,258,835 | 3.3 M to 3.3 M (+0.12 %) |
Mar 21 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 4.97 | 5,400 | 26,860 | 3,254,835 | 3.2 M to 3.3 M (+0.17 %) |
Mar 21 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 4.96 | 7,600 | 37,725 | 3,249,435 | 3.2 M to 3.2 M (+0.23 %) |
Dec 18 2017 | ZETAII | Aerpio Pharmaceuti ... | HOFFMAN STEPHEN J | Chief Executive Off ... | Option Exercise | A | 5.50 | 586,012 | 3,223,066 | 0 | |
Dec 18 2017 | ZETAII | Aerpio Pharmaceuti ... | Gardner Joseph H. | President | Option Exercise | A | 5.50 | 135,000 | 742,500 | 0 | |
Dec 18 2017 | ZETAII | Aerpio Pharmaceuti ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 5.50 | 293,006 | 1,611,533 | 0 | |
Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 762,995 | 3,814,975 | 4,416,446 | 3.7 M to 4.4 M (+20.88 %) |
Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | Gardner Joseph H. | See Remarks | Buy | P | 5.00 | 99,996 | 499,980 | 593,019 | 493 K to 593 K (+20.28 %) |
Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | WEISS PAUL M | Director | Buy | P | 5.00 | 272,302 | 1,361,510 | 1,576,167 | 1.3 M to 1.6 M (+20.88 %) |
Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 5.00 | 560,000 | 2,800,000 | 5,805,550 | 5.2 M to 5.8 M (+10.68 %) |
Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 5.00 | 1,120,000 | 5,600,000 | 3,241,835 | 2.1 M to 3.2 M (+52.78 %) |
Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | Castelein Caley | Director | Buy | P | 5.00 | 400,000 | 2,000,000 | 1,611,408 | 1.2 M to 1.6 M (+33.02 %) |
Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | Khuong Chau Quang | Director | Buy | P | 5.00 | 762,995 | 3,814,975 | 4,416,446 | 3.7 M to 4.4 M (+20.88 %) |
Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | PETERS KEVIN G. | Chief Scientific Of ... | Buy | P | 5.00 | 3,642 | 18,210 | 320,536 | 316.9 K to 320.5 K (+1.15 %) |
Page: 1